Short-term injection of antiapoptotic cytokine combinations soon after lethal γ-irradiation promotes survival

Blood

Volumn 101, Issue 7, 2003, Pages 2609-2616

  Hérodin, Francis ^a   Bourin, Philippe ^b   Mayol, Jean François ^b   Lataillade, Jean Jacques ^b   Drouet, Michel ^b  

^a CENTRE DE RECHERCHES   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND; INTERLEUKIN 3; PROTEIN TYROSINE KINASE; RECOMBINANT CYTOKINE; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; THROMBOPOIETIN; CYTOKINE; RADIOPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; GAMMA IRRADIATION; HEMATOPOIESIS; MACACA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; WHOLE BODY RADIATION; ANIMAL; CELL CYCLE; CYTOLOGY; DRUG COMBINATION; DRUG EFFECT; GAMMA RADIATION; HEMATOPOIETIC STEM CELL; MOUSE STRAIN; RADIATION EXPOSURE; RADIATION INJURY;

ANIMALS; APOPTOSIS; CELL CYCLE; CYTOKINES; DRUG THERAPY, COMBINATION; GAMMA RAYS; HEMATOPOIETIC STEM CELLS; MACACA FASCICULARIS; MALE; MICE; MICE, INBRED STRAINS; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; SURVIVAL RATE; WHOLE-BODY IRRADIATION;

EID: 17144458848     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-06-1634     Document Type: Article

References (46)

1. Monroy RL. Radiation effects on the lymphohematopoietic system: a compromise in immune competency. In: Conklin JJ, Walker RI, eds. Military Radiobiology. Orlando, FL: Academic Press; 1987:111-134.
2. Thierry D, Gourmelon P, Parmentier C, Nenot JC. Hematopoietic growth factors in the treatment of therapeutic and accidental irradiation induced bone marrow aplasia. Int J Radiat Biol. 1995;67:103-117.
3. MacVittie TJ, Farese AM. Cytokine-based treatment for acute radiation-induced myelosuppression: preclinical and clinical perspective. In: Ricks RC, Berger ME, O'Hara FM Jr, eds. The Medical Basis for Radiation Accident Preparedness. New York, NY: Parthenon Publishing Group; 2002:53-72.
4. Farese AM, Williams DE, Seiler FR, MacVittie TJ. Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage-colony-stimulating factor in a primate model of radiation-induced marrow aplasia. Blood. 1993;82:3012-3018.
5. Farese AM, Hunt P, Grab LB, MacVittie TJ. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. J Clin Invest. 1996;97:2145-2151.
6. Neelis KJ, Dubbelman YD, Qingliang L, Thomas R, Eaton DL, Wagemaker G. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells. Exp Hematol. 1997;25:1084-1093.
7. Jinaratana V. The radiological accident in Thailand. In: Ricks RC, Berger ME, O'Hara FM Jr, eds. The Medical Basis for Radiation Accident Preparedness. New York, NY: Parthenon Publishing Group; 2002:283-301.
8. Maekawa K. Overview of medical care for highly exposed victims in the Tokai Mura accident. In: Ricks RC, Berger ME, O'Hara FM Jr, eds. The Medical Basis for Radiation Accident Preparedness. New York, NY: Parthenon Publishing Group; 2002:313-318.
9. Li J, Xia Y, Bertino A, Coburn J, Kuter DJ. Characterization of an anti-thrombopoietin antibody that developing a cancer patient following the injection of Peg-rhuMGDF [abstract]. Blood. 1999;94:51.
10. Neta R, Oppenheim JJ. Cytokines in therapy of radiation injury. Blood. 1988;72:1093-1095.
11. Sureda A, Valls A, Kadar E, et al. A single dose of G-CSF modifies radiation-induced death in B6D2F1 mice. Exp Hematol. 1993;21:1605-1607.
12. Mouthon MA, Gaugler MH, Van der Meeren A, Vandamme M, Gourmelon P, Wagemaker G. Single administration of thrombopoietin to lethally irradiated mice prevents infectious and thrombotic events leading to mortality. Exp Hematol. 2001;29:30-40.
13. Drouet M, Mathieu J, Grenier N, Multon E, Sotto JJ, Hérodin F. The reduction of in vitro radiation-induced Fas-related apoptosis in CD34+ progenitor cells by SCF, Flt-3 ligand, TPO and IL-3 in combination resulted in CD34+ cell proliferation and differentiation. Stem Cells. 1999;17:273-285.
14. Domen J, Gandy KL, Weissman IL. Systemic overexpression of Bcl-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood. 1998;91:2272-2282.
15. Pestina TI, Cleveland JL, Yang C, Zambetti GP, Jackson CW. MPL-ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis. Blood. 2001;98:2084-2090.
16. Dainiak N. Hematologic consequences of exposure to ionizing radiation. Exp Hematol. 2002;30:513-528.
17. Van Bekkum DW. Radiation sensitivity of the hematopoietic stem cell. Radiat Res. 1991;128:S4-S8.
18. Lataillade JJ, Clay D, Dupuy C, et al. Chemokine SDF-1 enhances circulating CD34+ cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood. 2000;95:756-768.
19. Lataillade JJ, Clay D, Bourin P, et al. SDF-1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G0/G1 transition in cells: evidence for an autocrine/paracrine mechanism. Blood. 2002;99:1117-1129.
20. Ponomaryov T, Peled A, Petit I, et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest. 2000;106:1331-1339.
21. FitzGerald TJ, McKenna M, Rothstein L, Daugherty C, Kase K, Greenberger JS. Radiosensitivity of human bone marrow granulocyte-macrophage progenitor cells and stromal colony-forming cells: effect of dose rate. Radiat Res. 1986;107:205-215.
22. + cells. Br J Haematol. 2002;117:924-934.
23. Jordan CT, Yamasaki G, Minamoto D. High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations. Exp Hematol. 1996;24:1347-1355.
24. Hertveldt K, Philippé J, Thierens J, et al. Flow cytometry as a quantitative and sensitive method to evaluate low dose radiation induced apoptosis in vitro in human peripheral blood lymphocytes. Int J Radiat Biol. 1997;71:429-433.
25. Scarlett JL, Sheard PW, Hughes G, et al. Changes in mitochondrial membrane potential during stauroporine induced apoptosis in Jurkat cells. FEBS Lett. 2000;475:267-272.
26. Gale RP, Butturini A. Use of hematopoietic growth factors in radiation accidents. Int J Radiat Oncol Biol Phys. 1990;19:1291-1295.
27. Farese AM, Smith WG, Giri JG, Siegel N, McKearn JP, MacVittie TJ. Promegapoeitin 1A, an engineered chimeric IL-3 and MPL receptor agonist, stimulates hematopoietic recovery in conventional and abbreviated schedule following radiation-induced myelosuppression in nonhuman primates. Stem Cells. 2001;19:329-338.
28. Baranov AE, Selidovkin GD, Butturini A, Gale RP. Hematopoietic recovery after 10 Gy acute total body irradiation. Blood. 1994;83:596-599.
29. Negrin RS. Clinical applications of hematopoietic growth factors. In: Thomson AW, ed. The Cytokine Handbook. San Diego, CA: Academic Press; 1998:803-822.
30. Borge OJ, Ramsfjell V, Cui L, et al. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34-CD38-bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin. Blood. 1997;90:2282-2292.
31. Neelis KJ, Visser TP, Dimjati W, et al. A single dose of thrombopoietin shortly after myelosuppressive total body irradiation prevents pancytopenia in mice by promoting short term multilineage spleen repopulating cells at the transient expense of bone marrow repopulating cells. Blood. 1998;92:1586-1597.
32. Mouthon MA, Van der Meeren A, Gaugler MH, et al. Thrombopoietin promotes hematopoietic recovery and survival after high-dose whole body irradiation. Int J Radiat Oncol Biol Phys. 1999;43:867-875.
33. Abushullaih BA, Pestina TI, Srivastava DK, Jackson CW, Daw NC. A schedule of recombinant MPL ligand highly effective at preventing lethal myelosuppresion in mice given carboplatin and radiation. Exp Hematol. 2001;29:1425-1431.
34. Ulich TR, del Castillo J, Senaldi G, et al. The prolonged hematologic effects of a single injection of PEG-rhuMGDF in normal and thrombocytopenic mice. Exp Hematol. 1999;27:117-130.
35. Kuter DJ, Goodnough LT, Romo J, et al. Thrombopoietin therapy increases platelet yields in healthy platelet donors. Blood. 2001;98:1339-1345.
36. Dinarello CA. Interleukin-1. In: Thomson AW, ed. The Cytokine Handbook. San Diego, CA: Academic Press; 1998:35-72.
37. + cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. Blood. 2002;100:2463-2471.
38. + cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood. 2001;98:2091-2100.
39. Perez L, Alpdogan O, Shieh J, et al. In vivo effects of stromal derived factor 1 (SDF-1/CXCL12) on human megakaryocytopoiesis and mobilization of human hematopoietic progenitors [abstract]. Blood. 2001;98:799.
40. Croizat H, Frindel E, Tubiana M. Long-term radiation effects on the bone marrow stem cells of C3H mice. Int J Radiat Biol. 1979;36:91-99.
41. Wangenheim KH, Peterson HP, Hubner GE, Feinendegen LE. Long-term residual radiation effect in the murine hematopoietic stem cell compartment. Ann N Y Acad Sci. 1985;459:221-231.
42. Barnes DWH, Bungay GT, Mole RH. Delayed mortality after mid-lethal exposure to whole body irradiation and its modification by treatment with syngenic lymph node or bone marrow cells. Int J Rad Biol. 1966;11:409-427.
43. Knospe WH. Long-term bone marrow damage after irradiation. In: Testa NG, Gale RP, eds. Hematopoiesis: long-term effects of chemotherapy and radiation. New York, NY: Marcel Dekker; 1988:93-130.
44. Nothdurft W, Steinbach KH, Fliedner TN. Dose- and time-related quantitative and qualitative alterations in the granulocyte/macrophage progenitor cell (GM-CFC) compartment of dogs after total body irradiation. Radiat Res. 1984;98:332-344.
45. Cronkite EP, Inoue T, Hirabayashi Y. Are stem cells exposed to ionizing radiation in vivo as effective as nonirradiated transfused stem cells in restoring hematopoiesis? Exp Hematol. 1993;21:823-825.
46. Komarov PG, Komarova EA, Kondratov RV, et al. A chemical inhibitor of p53 that protects mice from side effects of cancer therapy. Science. 1999;285:1733-1737.